Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.

Mike Tarpley; Temesgen T Abdissa; Gary L Johnson; John E Scott

首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.

【24h】

Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.

机译：Bosutinib降低了Dasatinib在三阴性乳腺癌细胞系中的功效。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Bosutinib potently reduced the in vitro anti-proliferative efficacy of dasatinib in TNBC cell lines. We, hereby, report on a novel drug-induced loss in dasatinib sensitivity.

机译：Bosutinib可能会降低dasatinib在TNBC细胞系中的体外抗增殖功效。我们在此报告一种新型药物引起的达沙替尼敏感性下降。

著录项

来源
《Anticancer Research: International Journal of Cancer Research and Treatment》 |2014年第4期|共7页
作者
Mike Tarpley; Temesgen T Abdissa; Gary L Johnson; John E Scott;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines. [J] . Mike Tarpley, Temesgen T Abdissa, Gary L Johnson, Anticancer Research: International Journal of Cancer Research and Treatment . 2014,第4期

机译：Bosutinib降低了Dasatinib在三阴性乳腺癌细胞系中的疗效。
2. Dasatinib is synergistic with cetuximab and cisplatin in triple-negative breast cancer cells [J] . KimE.M.H., MuellerK., GartnerE., Journal of Surgical Research: Clinical and Laboratory Investigation . 2013,第1期

机译：达沙替尼与西妥昔单抗和顺铂在三阴性乳腺癌细胞中具有协同作用
3. Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro. [J] . Finn RS, Dering J, Ginther C, Breast cancer research and treatment. . 2007,第3期

机译：达沙替尼是src和abl激酶的口服活性小分子抑制剂，可选择性抑制体外生长的基础型/“三阴性”乳腺癌细胞系的生长。
4. Optical coherence elastography as a new method for estimation of chemotherapy efficacy on triple-negative breast cancer in the experiment [C] . Anton A. Plekhanov, Marina A. Sirotkina, Alexander A. Sovetsky, International Symposium on Optics and Biophotonics: Saratov Fall Meeting . 2019

机译：光学相干弹性造影作为对实验中三阴性乳腺癌化疗疗效估算的新方法
5. Screening for Small Molecule Dasatinib Sensitizers Using a Dasatinib-Resistant Breast Cancer Cell Line. [D] . Charla, Swapna. 2014

机译：使用耐达沙替尼的乳腺癌细胞系筛选小分子达沙替尼敏化剂。
6. Bosutinib Reduces the Efficacy of Dasatinib in Triple-negative Breast Cancer Cell Lines [O] . MIKE TARPLEY, TEMESGEN T. ABDISSA, GARY L. JOHNSON, -1

机译：Bosutinib降低Dasatinib在三阴性乳腺癌细胞系中的功效
7. Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer by Reduced Metabolic Degradation [O] . Fatemah Bahman, Valeria Pittalà, Mohamed Haider, 2021

机译：通过降低代谢降解，增强了达斯替尼的纳米型抗体抗癌活性对三重阴性乳腺癌
8. Targeting Breast Cancer Stem Cells in Triple-Negative Breast Cancer. [R] . 2015

机译：靶向三阴性乳腺癌中的乳腺癌干细胞。

Bosutinib reduces the efficacy of Dasatinib in triple-negative breast cancer cell lines.

摘要

著录项

相似文献

相关主题

期刊订阅